---
title: 2023 International HBV Meeting
description: PhoenixBio will present translatable human liver chimeric mouse and fresh human hepatocyte applications for HBV and HDV Research.
image: https://www.phoenixbio.com/hubfs/HBV%20Meeting%202023.png
---

13 September 2023

# 2023 International HBV Meeting

Post by PhoenixBio Team

![Topics icon](https://www.phoenixbio.com/hubfs/Blend01/Template%20Files/tag_icon.svg) [Events](https://www.phoenixbio.com/news/tag/events)

![International HBV Meeting 2023](https://www.phoenixbio.com/hs-fs/hubfs/HBV%20Meeting%202023.png?width=501&name=HBV%20Meeting%202023.png)

[Back to blog](https://www.phoenixbio.com/news)

PhoenixBio is delighted to be attending the International HBV Meeting in person at the Kobe International Conference Center in Kobe, Japan on September 19th - 23rd, 2023. We'll be sponsoring the conference and providing talks on preclinical models. Meet with our team to learn more about PhoenixBio's capabilities and how we can help you advance and deliver tomorrow’s therapies.

Featured PhoenixBio Talks:  
Title: PXB-Mouse and Hepatitis D virus infections: Exploring potential HDV therapeutics using the world’s most widely used human liver chimeric mouse model  
Speakers: Amanda Burmeister, Ph.D., Senior RPBD Representative  
Date: Thursday, September 21, 2023  
Time: 13:00 - 14:00  
Room: 307 (3rd Floor)

Get ready for everything you need to know about viral hepatitis in 2023 and beyond! The International HBV Meeting will cover a range of topics from cutting-edge studies in hepatitis B and D viruses (HBV and HDV), the development of new technologies and analytical methods for understanding HBV and HDV infection, joint discussion on the latest therapeutic development with patients and clinicians, and opportunities to network with the HBV/HDV community.

While you're there, be sure to attend PhoenixBio's talk featured above and grab a chance to speak with our team by booking a meeting below!

[![Book a Meeting!](https://no-cache.hubspot.com/cta/default/19881682/000bd0a5-4251-4917-b1e8-28953d7d07f2.png)](https://cta-redirect.hubspot.com/cta/redirect/19881682/000bd0a5-4251-4917-b1e8-28953d7d07f2)

 

[Previous post](https://www.phoenixbio.com/news/attending-eurotox-2023)[Back to blog](https://www.phoenixbio.com/news)[Next post](https://www.phoenixbio.com/news/unlocking-the-future-of-aav-based-gene-therapies)

### Sign-up to our newsletter for the latest news and information straight to your inbox

```json
{
  "@context" : "https://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "PhoenixBio Team",
    "url" : "https://www.phoenixbio.com/news/author/phoenixbio-team"
  },
  "dateModified" : "2023-09-13T09:58:13.649Z",
  "datePublished" : "2023-09-13T09:58:13.000Z",
  "headline" : "2023 International HBV Meeting",
  "mainEntityOfPage" : {
    "@id" : "https://www.phoenixbio.com/news/attending-international-hbv-meeting-2023",
    "@type" : "WebPage"
  },
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "url" : "https://www.phoenixbio.com/hubfs/PhoenixBio-Horz-RGB-2.png"
    },
    "name" : "PhoenixBio USA Corporation"
  }
}
```